COR Q3 2024 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q3 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$74.2B+10.9% YoY

Gross Profit

$2.1B2.8% margin

Operating Income

$703M0.9% margin

Net Income

$483M0.7% margin

EPS (Diluted)

$2.42

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.4B

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$66.8B

Total Liabilities

$65.7B

Stockholders' Equity

$925M

Cash & Equivalents

$3.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74.2B	$66.9B	+10.9%
Gross Profit	$2.1B	$1.9B	+11.5%
Operating Income	$703M	$568M	+23.9%
Net Income	$483M	$480M	+0.8%

Revenue Segments

Pharmaceutical Distribution

$65.8B89%

International Healthcare Solutions

$7.1B9%

Animal Health

$1.4B2%

Geographic Segments

U.S. Healthcare Solutions

$67.2B91%

International Healthcare Solutions

$7.1B9%